European stocks were mixed as the U.S. government shutdown began after the Senate failed to pass a spending bill. The pan European Stoxx 600 rose 0.2%, with the U.K.’s FTSE 100 climbing 0.7% due to accelerated house price growth in September. Pharma stocks rose after Pfizer’s deal with the U.S. government, while Tate & Lyle, Plc fell 10% after lowering revenue outlook. Vallourec rallied 2.2% on a new order from Petrobras, Greggs soared 8.2% on sales growth, and Technip Energies gained 1% on new contracts. Diageo rose 2% after pricing bonds, and Arcadis surged 8% on share buyback news.

Read more at Nasdaq: European Shares Mixed As US Government Shutdown Adds To Uncertainty